ArticlePloS one2015

Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade.

Albert Do et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.